Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stonebraker JS et al. – With improved information, healthcare agencies can assess budgetary needs to develop better diagnostic and treatment facilities for affected patients and families and work to ensure adequate supplies of factor VIII concentrates for treatment. In addition, this information can help manufacturers plan the production of concentrates and prevent future shortages.

Related Articles

Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A
Journal of Thrombosis and Haemostasis, 10/28/09    Relevance Score: 69%

Functional independence score in hemophilia: A cross-sectional study assessment of Mexican children
Pediatric Blood & Cancer, 10/08/09    Relevance Score: 68%

Kinetics of factor VIII:C inhibitors and treatment response in severe hemophilia A patients
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 66%

Study of mutations in Jordanian patients with haemophilia A: identification of five novel mutations
Haemophilia, 10/12/09    Relevance Score: 66%

The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis
Blood Coagulation & Fibrinolysis, 10/05/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address